Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
REalloys Inc (ALOY)
NASDAQMaterialsOther Precious MetalsSnapshot 2026-11-04
$5.86-12.01%
Close 2026-11-05 · 1-day change
NASDAQMaterialsOther Precious MetalsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for ALOY yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage capital allocation to support growth and liquidity | Capital raising supports liquidity despite current losses. | Improving | Failure to raise capital leading to liquidity crisis | Cash $119M vs burn coverage target Private placement executed; $119M cash reported; earnings missed but revenue topped estimates. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, project-led rare earth growth story, not a proven durable compounder: earnings remain loss-making, recent performance is weak, and management has been volatile. The thesis is on watch, with some improvement in company momentum after fresh earnings but no clear break in the underlying concerns.
The evidence snapshot gives no valuation or market-expectations measures, so it is not possible to judge whether ALOY is cheap, fair, or expensive versus peers, or what expectations are already reflected. The available evidence points to weak results and substantial project execution needs, rather than a clear expectations gap.
Near term, the risk of another earnings miss is elevated: ALOY has missed in recent quarters, including its latest quarter. Over the multi-year view, management has fully funded upgrades targeting 525 tonnes of annual NdPr capacity for commercial intake in Q3 2027 and 50 tonnes of heavy rare earth capacity for commissioning in Q1 2028, while advancing feedstock agreements; execution remains mixed.
The multi-year thesis hinges on funding, commissioning, and operating the planned facilities, while securing enough reliable feedstock. Near-term sector support could persist if bellwethers keep beating and raising guidance, but weaker results from those companies or further job-market weakness could erode the tailwind for cyclical Materials names.
Over the next 1 to 3 years, ALOY offers a project-development thesis with meaningful capacity milestones, but weak financial performance, an elevated miss risk, and mixed execution leave the evidence uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Capital raising supports liquidity despite current losses. |
| Broken |
| Operating losses worsen beyond -$87.7M in FY26 |
Operating income: $-36.804M FY2026-Q2; GAAP. Published target: Reduce operating losses significantly from -$87.7M in 2026-Q1. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 2026-36,804,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Grow revenue from current low levels | A primary condition in REalloys Inc's published investment case. The stated target is Achieve revenue growth to at least $23.8M by FY27. | Improving | Revenue fails to grow beyond $2.8M in FY26 or $23.8M in FY27 | Revenue: $804,000 FY2026-Q2; GAAP. Published target: Achieve revenue growth to at least $23.8M by FY27. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 2026804,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Secure and maintain rare earth supply agreements | REalloys secures long-term rare earth supply with 15-year deals. | Improving | Failure to secure or maintain key supply agreements within next year | 3 new supply agreements secured (Jun 2026) vs target to maintain/expand News confirms Ramaco, Patriot, and Critical Metals supply agreements signed in June 2026, reinforcing the competitive moat driver. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.21 → $-0.21 · observed estimates
$0.03B → $0.04B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.21 | $31,065,500 | 1 / 1 |
| 2026-07-25 | $-0.21 | $31,065,500 | 1 / 1 |
| 2026-07-26 | $-0.21 | $31,065,500 | 1 / 1 |
| 2026-07-27 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-07-28 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-07-29 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-07-30 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-07-31 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-01 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-02 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-03 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-04 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-05 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-06 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-07 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-08 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-09 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-10 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-11 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-12 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-13 | $-0.14 | $29,415,500 | 2 / 2 |
| 2026-08-14 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-15 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-16 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-17 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-18 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-19 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-20 | $-0.14 | $32,377,000 | 1 / 1 |
| 2026-08-21 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-22 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-23 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-24 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-25 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-26 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-27 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-28 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-29 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-30 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-08-31 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-09-01 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-09-02 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-09-03 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-09-04 | $-0.16 | $32,843,667 | 1 / 1 |
| 2026-09-05 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-06 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-07 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-08 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-09 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-10 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-11 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-12 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-13 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-14 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-15 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-16 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-17 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-18 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-19 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-20 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-21 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-22 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-23 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-24 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-25 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-26 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-27 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-28 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-29 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-09-30 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-01 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-02 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-03 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-04 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-05 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-06 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-07 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-08 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-09 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-10 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-11 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-12 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-13 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-14 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-15 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-16 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-17 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-18 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-19 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-20 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-21 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-22 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-23 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-24 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-25 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-26 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-27 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-28 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-29 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-30 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-10-31 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-11-01 | $-0.11 | $37,350,000 | 1 / 1 |
| 2026-11-02 | $-0.21 | $39,700,000 | 1 / 1 |
| 2026-11-03 | $-0.21 | $39,700,000 | 1 / 1 |
| 2026-11-04 | $-0.21 | $39,700,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.